Glenmark generics unit launches azathioprine in US
MUMBAI (Reuters) - Drugmaker Glenmark Pharmaceuticals Ltd said on Thursday its generics unit has launched azathioprine tablets in the United States.
Glenmark Generics Ltd acquired full marketing rights for the drug from an unnamed company, the company said in a statement.
Azathioprine is a generic version of Imuran, used to prevent rejection in kidney transplantation. It is also used to treat rheumatoid arthritis, Glenmark said in a statement.
Imuran had sales of about $36 million for the 12 months to June 2008, the company added.
© Thomson Reuters 2009 All rights reserved
One Year Later
A year after militants laid siege to Mumbai, the country still remains very vulnerable. Full Article | Full Coverage
Liberhan Commission Report
The government published a long awaited report, recently leaked, accusing BJP leaders of a role in the 1992 destruction of the Babri mosque in Ayodhya. Full Article
